Progress Report Global Pandemic Preparedness Beijing Conference 17-18 January 2006 Dr Margaret Chan Assistant Director-General Communicable Diseases Representative.

Slides:



Advertisements
Similar presentations
Keynote Address: Issues to Tackle David Nabarro Vienna Senior Officials Meeting on Avian and Pandemic Influenza 7 th June 2006.
Advertisements

The Work of WHO in the South-East Asia Region Member countries made steady progress in health development Health development WHO focused on country.
Avian Influenza Prevention and Control from an OIE Perspective T. Fujita OIE Regional Representative for Asia and the Pacific, World Organisation for Animal.
Addressing Financing Gaps: Cambodia’s Experience International Pledging Conference on Avian and Human Pandemic Influenza Beijing, January 2006.
JUNIADEE AHMAD (Acting) Chief Executive Officer Public Relation Division Ministry of Health Brunei Darussalam.
Wrap-up of Day 1. Plenary One: Regional and Global Update Update of global situation and response to pandemic (H1N1) Dr Wenqing Zhang Regional.
Highly Pathogenic Avian Influenza IN EGYPT Presentation by Prof. Dr. Hamed Samaha CVO, GOVS HPAI Technical Meeting Rome, June.
Regional Health Focus Rome | 27 – 29 June |1 | Health Focus WHO Regional Perspective FAO/ OIE/ WHO Technical Meeting on Highly Pathogenic Avian.
Avian Influenza: The Challenge to Africa and USAID’s Response March 7, 2006 Southern Africa Regional Workshop on Notifiable Avian Influenza.
Ebola Virus Disease Crisis in Western Africa Dr Marcos Espinal Director, Communicable Diseases and Health Analysis Washington DC, 24 September 2014.
U.S. Pandemic Influenza Preparedness and Response: Planning and Activities “The pandemic influenza clock is ticking. We just don’t know what time it is.”
Communicable Disease Surveillance & Response WHO-WPRO Pandemic (H1N1) 2009 situation and response in the Western Pacific Region Takeshi Kasai Communicable.
Avian Influenza A(H5N1) and Risks to Human Health Technical Meeting on Highly Pathogenic Avian Influenza and Human H5N1 infection Rome June 2007.
Pandemic Influenza Catherine Donovan, MD. MHSc. CIPHI, Newfoundland and Labrador, Oct 25, 2005 Eastern Region
1 Avian Influenza Rapid Response Team Training. 2 What is a Rapid Response Team? A team of professionals that investigates suspected cases of avian influenza.
1. 2 The Public Health Agency of Canada Pandemic Influenza Preparedness: An Overview Dr. Paul Gully Deputy Chief Public Health Officer Ottawa, 19 January.
Confederation of Health Care Systems Israel – 2008 Lori Post Yale University School of Medicine.
SARS Epidemic: A Global Challenge Bong-Min Yang, PhD & Sung-il Cho, MD, PhD of School of Public Health Seoul National University.
The Work of WHO in the South-East Asia Region The Work of WHO in the South-East Asia Region Biennial Report of the Regional Director 1 January
Pandemic Influenza Preparedness Kentucky Department for Public Health Department for Public Health.
World Health Organization 1 August 2008 Health security under the International Health Regulations.
The Quality Management System
Departmental Perspectives on Viral Hepatitis
Protecting American Agriculture 1 The Wild Bird Population: An Early Warning System for Avian Influenza Dr. Ron DeHaven Administrator USDA Animal and Plant.
PANDEMIC RISK. 3 pre-requisites for a Pandemic 1. The emergence of a new virus strain with no circulating immunity within the human population 2. The.
WHO COLLABORATION | September 13, | WHO Indonesia Collaboration with Animal Health.
Raymond A. Strikas, MD Associate Director for Adult Immunization Immunization Services Division National Immunization Program Coordinating Center for Infectious.
Emerging Diseases – Ready and Waiting Aileen J Plant Curtin University of Technology 19 October, 2004 Emerging Diseases: the human health perspective.
The Global Threat of Avian and Human Influenza Stocktaking: Conclusions of Geneva & Review of Recent Progress David Nabarro United Nations System Influenza.
Controlling and Eradicating Highly Pathogenic Avian Influenza in ASEAN Dr. Wilfrido V. Villacorta ASEAN Deputy Secretary-General International Pledging.
1 WHO Communicable Diseases, Surveillance & Response SARS Diagnostics and Laboratory Needs: the WHO Perspective C.E. Roth Dangerous and New Pathogens Global.
TASK FORCE ON WRDs SURVEILLANCE TASK FORCE ON WRDs SURVEILLANCE Monica Francesca Blasi, Paola Meli, Mario Carere, Enzo Funari National Institute of Health.
HHS Pandemic Influenza Preparedness Planning Julie Louise Gerberding, MD, MPH.
Conclusions and Next steps Conclusions and Next steps EVD Preparedness Meeting: January 2015.
CDC’s Global Disease Detection Program
Health Security and Emergencies Ebola Response 13 October 2014.
Text WHO Global Influenza Programme NIC Role during a pandemic and NIC contingency plan Wenqing Zhang MD Global Influenza Programme, WHO HQ THE 3rd MEETING.
World Health Organization, Regional Office for The Western Pacific Regional Activities Report and Preparation for the Upcoming Influenza Seasons THE 3rd.
Introduction The World Bank is pleased to offer a series of inter- regional knowledge and learning seminars where institutions, governments, technical.
Food and Drug Administration
ASDPE Asia Pacific Strategy for Emerging Diseases (2010) and Influenza Activities Health Security and Emergencies (DSE) WHO Western Pacific Regional Office.
Result of gap analysis and framework of action required in coming five months August rd Meeting of National Influenza Centres in the Western.
Mitigating the Impact of Pandemic (H1N1): Options for Public Health Measures Dr Li Ailan Communicable Disease Surveillance & Response (CSR) WHO Western.
Central Asia Regional Health Security Workshop George C. Marshall European Center for Security Studies April 2012, Garmisch-Partenkirchen, Germany.
The Vermont Department of Health Overview of Pandemic Influenza Regional Pandemic Planning Summits 2006 Guidance Support Prevention Protection.
Communicable Disease Surveillance and Response, WHO Avian Influenza Credit: WHO Viet Nam.
Pandemic Preparedness Rome | June |1 | Pandemic Preparedness FAO/ OIE/ WHO Technical Meeting on Highly Pathogenic Avian Influenza, June,
Update on Coordinated International Assistance Olga Jonas, Avian and Human Influenza Global Program Coordinator, World Bank Presentation in Session X NEW.
1 |1 | Situation Update Influenza A (H1N1), 26 May 09.
DRAFT PIP Framework Partnership Contribution: Factors to consider in selecting countries DRAFT PIP Framework Partnership Contribution: Factors to consider.
International Health Regulations (IHR) Dr. Ibrahim Gosadi & Dr. Salwa Tayel Family & Community MedicineDepartment May_
Conclusions 3 rd Meeting of National Influenza Centres in the Western Pacific and South East Asia Regions 18 – 20 August 2009 Beijing, China.
DADF-NIC. Department of Animal Husbandry, Dairying & Fisheries, New Delhi State Veterinary Services Directorate District Veterinary Services.
Exposure Rostering: Population Tracking Following a Disaster Melissa E. Powell, MPH Michelle F. Barber, MS Preparedness, Surveillance & Epidemiology PUBLIC.
Emerging and Re-emerging Infectious Diseases Challenges and Opportunities for Militaries LTC (Dr) Vernon Lee MBBS, PhD, FAMS, MPH,MBA Singapore Armed Forces.
ASDPE International Health Regulations (IHR 2005) Laboratory and Zoonosis update Dr Richard Brown, WHO Thailand Workshop on Laboratory Diagnosis for Zoonotic.
THE PHILIPPINES’ RESPONSE TO PANDEMIC (H1N1) 2009 Presented by: Remigio M. Olveda, MD, Director National Influenza Center,Research Institute for Tropical.
National Influenza Centres in SEA Region Dr Rajesh Bhatia / Dr Oommen John WHO Regional Office for South-East Asia New Delhi 5 th Meeting of NIC in Western.
Zika Response Strategy
Pandemic Influenza: Planning and Preparedness Ben Schwartz, M.D. National Vaccine Program Office, U.S. Department of Health and Human Services NVAC Meeting,
World Organisation for Animal Health. 2 «Global and Regional Perspective » «Global and Regional Perspective » Dr Bernard Vallat Director General International.
ASDPE Regional Plan for Strengthening the National Influenza Surveillance Capacity: Guiding the way towards a comprehensive National Influenza Surveillance.
Influenza Pandemic Preparedness and Response Ministry of Health, National Centre for Communicable Diseases, Mongolia 1.
PANDEMIC H1N1 IN HANOI-VIETNAM: OVERVIEW AND RESPONSE.
Overview of the Objectives, Expected Outcomes, and Meeting Agenda
World Health Organization
The role of the OIE in biological threat reduction
The Role of NICs in Influenza Surveillance
Avian Influenza Prevention and Control from an OIE Perspective
Workshop on the Revised WHO Guidance
Presentation transcript:

Progress Report Global Pandemic Preparedness Beijing Conference January 2006 Dr Margaret Chan Assistant Director-General Communicable Diseases Representative of the Director-General for Pandemic Influenza The World Health Organization

Where we stand today Current phase 3 of pandemic alert remains unchanged  H5N1 is still mainly an animal disease; no sustained human-to-human transmission.  Sporadic cases in 6 countries; in 2006, cases reported in Turkey, China and Indonesia.  WHO team in Turkey, good data from outbreak.

Progress Since Geneva Meeting (1)  Meeting on pandemic communications, 6-8 December. RESULT: global support networks and strategic working groups established  GOARN partners meeting in Singapore, 8-9 December. RESULT: increased regional collaboration in Asia Pacific region.  Informal meeting on use of WHO antiviral stockpile, 12 December. RESULT: agreement on principles of operational protocol, SOP; follow-up meeting on rapid containment, Tokyo January.  Report for January EB on voluntary compliance with relevant provisions of IHR. RESULT: draft resolution  WHO Strategic Action Plan January RESULT: 2-year plan.

Progress Since Geneva Meeting (2)  Task forces in place at HQ, Regional Offices (RO); ROs have conducted inter-country meetings, geared up support to countries. RESULT: almost all countries have preparedness plans.  Immediate regional and HQ support to countries with diagnosis, management, investigation of new cases. RESULT: constantly improving knowledge about the virus and pandemic risk, improved country capacity, better surveillance and detection.  Regional needs for antiviral drugs assessed. Negotiations with manufacturer, generic manufacturing to start. RESULT: more drugs.  Three meetings on pandemic vaccines first half EXPECTED RESULT: global action plan to increase access; easier exportation.

Next Steps 5 Strategic actions for the next 2 yearsGoal Reduce human exposure to the H5N1 virusReduce opportunities for human infection, thus reducing opportunities for pandemic virus to emerge. Strengthen early warning systemEnsure that all data and specimens needed for risk assessment are available. Intensify rapid response and containment operations Prevent the virus from improving its transmissibility or delay pandemic spread. Build capacity to cope with a pandemicResponse plans in all countries (rehearsed); WHO fully able to perform leadership role. Coordinate global scientific research and development Make vaccines and drugs quickly and widely available; understand evolving pandemic.